The ETO domain is necessary for the developmental abnormalities associated with AML1-ETO expression in the hematopoietic stem cell compartment in vivo

Blood Cells, Molecules, and Diseases

Volumn 30, Issue 2, 2003, Pages 201-206

  De Guzman, Cristina G ^a   Johnson, Amanda ^b   Klug, Christopher A ^b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

AML1 ETO; Hematopoietic stem cell; Leukemia; Myeloid development

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN; PROTEIN; PROTEIN ETO; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; EOSINOPHIL; GENE EXPRESSION; GENE TRANSLOCATION; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MYELOBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REPORTER GENE;

ANIMALIA;

EID: 0038300361     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00025-1     Document Type: Article

References (26)

1. Rowley J.D. The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet. 32:1998;495-519.
2. Nucifora G., Rowley J.D. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood. 86:1995;1-14.
3. Pui C.-H. Childhood leukemias. N. Engl. J. Med. 332:1995;1618-1630.
4. Kersey J.H. Fifty years of studies of the biology and therapy of childhood leukemia. Blood. 90:1997;4243-4251.
5. Rubnitz J.E., Look A.T. Molecular genetics of childhood leukemias. J. Ped. Hem. Oncol. 20:1998;1-11.
6. Downing J.R. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia biology and clinical significance . Br. J. Haematol. 106:1999;296-308.
7. Speck N.A., Stacy T., Wang Q., North T., Gu T.-L., Miller J., Binder M., Marin-Padilla M. Core-binding factor a central player in hematopoiesis and leukemia . Cancer Res. 59:1999;1789-1793.
8. Wang Q., Stacy T., Miller J.D., Lewis A.F., Gu T.-L., Huang X., Bushweiler J.H., Bories J.-C., Alt F.W., Ryan G., Liu P.P., Wynshaw-Boris A., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell. 87:1996;697-708.
9. Meyers S., Downing J.R., Hiebert S.W. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as a sequence-specific DNA-binding protein the runt homology domain is required for DNA binding and protein-protein interactions . Mol. Cell. Biol. 13:1993;6336-6345.
10. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the CBFa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA. 93:1996;3444-3449.
11. Okuda T., Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
12. Sasaki K., Yagi H., Bronson R.T., Tominaga K., Matsunashi T., Deguchi K., Tani Y., Kishimoto T., Komori T. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor β Proc. Natl. Acad. Sci. USA. 93:1996;12359-12363.
13. Erickson P.F., Dessev G., Lasher R.S., Philips G., Robinson M., Drabkin H.A. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors implications for t(8;21) leukemogenesis and monitoring residual disease . Blood. 88:1996;1813-1823.
14. Lutterbach B., Westendorf J.J., Linggi B., Patten A., Moniwa M., Davie J.R., Huynh K.D., Bardwell V.J., Lavinsky R.M., Rosenfeld M.G., Glass C., Seto E., Hiebert S.W. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol. Cell. Biol. 18:1998;7176-7184.
15. Lutterbach B., Westendorf J.J., Linggi B., Isaac S., Seto E., Hiebert S.W. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J. Biol. Chem. 275:2000;651-656.
16. Yergeau D.A., Hetherington C.J., Wang Q., Zhang P., Sharpe A.H., Binder M., Marin-Padilla M., Tenen D.G., Speck N.A., Zhang D.E. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nature Genet. 15:1997;303-306.
17. Okuda T., Cai Z., Yang S., Lenny N., Lyu C., van Deursen J., Harada H., Downing J. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood. 91:1998;3134-3143.
18. Westendorf J.J., Yamamoto C.M., Lenny N., Downing J.R., Selsted M.E., Hiebert S.W. The t(8;21) fusion product, AML1-ETO, associates with C/EBP-α, inhibits C/EBP-α-dependent transcription, and blocks granulocytic differentiation. Mol. Cell. Biol. 18:1998;322-333.
19. de Guzman C.G., Warren A.J., Zhang Z., Gartland L., Erickson P., Drabkin H., Hiebert S.W., Klug C.A. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. Mol. Cell. Biol. 22:2002;5506-5517.
20. Hawley R.G., Lieu F.H.L., Fong A.Z.C., Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:1994;136-138.
21. Pear W.S., Nolan G.P., Scott M.L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
22. Klug C.A., Cheshier S., Weissman I.L. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood. 96:2000;894-901.
23. Anderson M.T., Tjioe I.M., Lorincz M.C., Parks D.R., Herzenberg L.A., Nolan G.P., Herzenberg L.A. Simultaneous fluorescence-activated cell sorter analysis of two distinct transcriptional elements within a single cell using engineered green fluorescent proteins. Proc. Natl. Acad. Sci. USA. 93:1996;8508-8511.
24. Lagasse E., Weissman I.L. Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Methods. 197:1996;139-150.
25. Morrison S.J., Wandycz A.M., Hemmati H.D., Wright D.E., Weissman I.L. Identification of a lineage of multipotent hematopoietic progenitors. Development. 124:1997;1929-1939.
26. Swirsky D.M., Li Y.S., Matthews J.G., Flemans R.J., Rees J.K.H., Hayhoe F.G.J. 8;21 translocation in acute granulocytic leukaemia cytological, cytochemical and clinical features . Br. J. Haematol. 56:1984;199-213.